Information Journal Paper
APA:
Copy. (2018). Tofogliflozin decreases body fat mass and improves peripheral insulin resistance. DIABETES OBESITY AND METABOLISM, 20(-), 1311-1315. SID. https://sid.ir/paper/692155/en
Vancouver:
Copy. Tofogliflozin decreases body fat mass and improves peripheral insulin resistance. DIABETES OBESITY AND METABOLISM[Internet]. 2018;20(-):1311-1315. Available from: https://sid.ir/paper/692155/en
IEEE:
Copy, “Tofogliflozin decreases body fat mass and improves peripheral insulin resistance,” DIABETES OBESITY AND METABOLISM, vol. 20, no. -, pp. 1311–1315, 2018, [Online]. Available: https://sid.ir/paper/692155/en